このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effect of Low Level Laser Therapy on Women With Obstructive Defecation Syndrome

2026年8月13日 更新者:Doaa A. Osman、Cairo University

Effect of Low Level Laser Therapy on Women With Obstructive Defecation Syndrome: A Randomized Controlled Trial

Obstructive defecation syndrome (ODS) is a condition in which a person has difficulty completely emptying the rectum during bowel movements. Women with ODS may experience excessive straining, a feeling of incomplete evacuation or blockage, abdominal discomfort, and the need to use manual assistance, laxatives, or enemas to facilitate defecation.

This randomized controlled trial will investigate the effect of adding low-level laser therapy (LLLT) to a conventional treatment program for women with ODS. Participants will be randomly assigned to one of two groups. The control group will receive nutritional modification and biofeedback training, while the study group will receive the same treatment in addition to low-level laser therapy applied to the lumbosacral region.

The study will evaluate whether adding low-level laser therapy can improve anorectal function, reduce the severity of ODS symptoms, and improve health-related quality of life compared with conventional treatment alone.

調査の概要

詳細な説明

This study is a prospective, randomized, pre-posttest controlled trial designed to investigate the effect of low-level laser therapy (LLLT) as an adjunct to conventional treatment in women with obstructive defecation syndrome (ODS).

Women diagnosed with ODS will be randomly assigned to two groups. Participants in the control group will receive nutritional modification and biofeedback training. Nutritional modification will focus on dietary fiber intake, adequate hydration, and weight-management recommendations. Biofeedback training will provide real-time feedback to facilitate appropriate pelvic floor muscle control, relaxation, and coordination during defecation.

Participants in the study group will receive the same nutritional modification and biofeedback program in addition to low-level laser therapy. LLLT will be applied to the lumbosacral region, targeting the lumbar (L2-L5) and sacral (S1-S5) areas.

Participants will be assessed before and after the intervention. Anorectal manometry will be used to evaluate anorectal physiological parameters, including anal resting pressure, squeeze pressure, strain pressure, endurance, rectal sensitivity, and rectal compliance. The severity of obstructive defecation symptoms will be evaluated using the Renzi Obstructive Defecation Syndrome Score, and health-related quality of life will be assessed using the Short Form-36 Health Survey (SF-36).

The study aims to determine whether adding low-level laser therapy to nutritional modification and biofeedback training provides additional benefits in anorectal function, ODS symptom severity, and quality of life compared with nutritional modification and biofeedback training alone.

研究の種類

介入

入学 (推定)

40

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

  • 名前:Radwa Ayad Mohamed, M.Sc

研究場所

      • Giza、エジプト
        • Faculty of Physical Therapy, Cairo University
        • コンタクト:
        • コンタクト:
          • Radwa Ayad Mohamed, M.Sc

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Woman diagnosed with ODS according to the Renzi ODS score (≥ 9).
  • They suffer from difficult defecation for at least three months.
  • Their ages will range from 30-45 years old.
  • Their body mass index (BMI) will range from 25-30 kg/m2.
  • Their parity number will be 2-3 times.

Exclusion Criteria:

  • Any abnormalities around cancer colon, interstitial cystitis, or endometriosis.
  • Enlarged rectal diameter and damaged mienteric plexus and abnormal motor function of rectum.
  • Psychological or mental health problems.
  • Pregnancy and lactation
  • A history of previous pelvic surgery.
  • A history of retinopathy.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Nutritional modification + Biofeedback muscle training
It will consist of 20 women with Obstructive Defecation Syndrome. They will be treated by nutritional modification and biofeedback muscle training, twice weekly for 8 weeks.
Participants will receive nutritional modification throughout the intervention period. The program will include a fiber-rich diet containing both soluble and insoluble fiber to improve stool consistency and facilitate bowel movements. Participants will also be instructed to maintain adequate hydration by consuming approximately 6-8 glasses of water per day. The nutritional modification program will be applied to participants in both the control and study groups.
Participants will receive anorectal biofeedback training using a rectal biofeedback device that provides real-time visual or auditory feedback on pelvic floor muscle activity. During each session, participants will be trained to improve pelvic floor muscle coordination and relaxation during simulated defecation. They will be instructed to consciously relax and release the pelvic floor muscles, use deep abdominal breathing, and practice relaxation techniques while observing the biofeedback signals. Exercises will be repeated approximately 10-20 times per session according to participant tolerance and therapist assessment. The intervention will be administered twice weekly.
実験的:Low level laser therapy + Nutritional modification + Biofeedback muscle training
It will consist of 20 women with Obstructive Defecation Syndrome. They will be treated by the same nutritional modification and biofeedback muscle training, in addition to low level laser therapy, twice weekly for 8 weeks.
Participants will receive nutritional modification throughout the intervention period. The program will include a fiber-rich diet containing both soluble and insoluble fiber to improve stool consistency and facilitate bowel movements. Participants will also be instructed to maintain adequate hydration by consuming approximately 6-8 glasses of water per day. The nutritional modification program will be applied to participants in both the control and study groups.
Participants will receive anorectal biofeedback training using a rectal biofeedback device that provides real-time visual or auditory feedback on pelvic floor muscle activity. During each session, participants will be trained to improve pelvic floor muscle coordination and relaxation during simulated defecation. They will be instructed to consciously relax and release the pelvic floor muscles, use deep abdominal breathing, and practice relaxation techniques while observing the biofeedback signals. Exercises will be repeated approximately 10-20 times per session according to participant tolerance and therapist assessment. The intervention will be administered twice weekly.
Participants in the study group will receive low-level laser therapy (LLLT) using a Scanner Laser PR 999 4W device with dual wavelengths (continuous 808 nm and pulsed 940 nm). LLLT will be applied to the lumbosacral region, targeting the lumbar (L2-L5) and sacral (S1-S5) areas. Participants will be positioned prone, and the laser scanner will be applied perpendicular to the skin at a 90° angle, approximately 1-2 inches above the treatment area. The scanner will be moved slowly to provide uniform coverage of the lumbosacral region. Each treatment session will last 30 minutes and will be administered twice weekly for 8 weeks. Both participants and therapists will wear appropriate protective eyewear during treatment.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Obstructive Defecation Syndrome Severity Assessed by the Renzi ODS Score
時間枠:8 weeks
The severity of obstructive defecation syndrome (ODS) will be assessed using the Renzi ODS Score. The scale consists of five items assessing excessive straining, incomplete rectal evacuation, use of enemas and/or laxatives, vaginal-anal-perineal digitations, and abdominal discomfort and/or pain. The total score ranges from 0 to 20, with higher scores indicating greater severity of ODS symptoms. A score of ≥9 is used to identify ODS.
8 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Anal Resting Pressure Assessed by Anorectal Manometry
時間枠:8 weeks
Anal resting pressure will be assessed using anorectal manometry. After insertion of the anorectal manometry probe, the participant will be allowed to relax for approximately 3-5 minutes to allow anal sphincter tone to return to baseline. Basal anal pressure will then be recorded at rest over 60 seconds. The outcome will be expressed in mmHg.
8 weeks
Anal Squeeze Pressure Assessed by Anorectal Manometry
時間枠:8 weeks
Anal squeeze pressure will be assessed using anorectal manometry during voluntary contraction of the anal sphincter and pelvic floor muscles. Participants will perform three maximum voluntary squeezes, each maintained for approximately 5 seconds, with a 30-second recovery period between attempts. The average pressure obtained from the three attempts will be used for analysis and expressed in mmHg.
8 weeks
Anal Strain Pressure Assessed by Anorectal Manometry
時間枠:8 weeks
Anal strain pressure will be assessed using anorectal manometry during simulated defecation. Participants will be instructed to perform a bearing-down maneuver to simulate defecation. Three straining attempts will be performed, with each attempt lasting approximately 15 seconds and separated by a 30-second recovery interval. The average pressure obtained from the three attempts will be used for analysis and expressed in mmHg.
8 weeks
Anal Sphincter Endurance Assessed by Anorectal Manometry
時間枠:8 weeks
Anal sphincter endurance will be assessed using anorectal manometry during a sustained maximum voluntary contraction. Endurance will be defined as the length of time for which the participant can maintain pressure during the maximum voluntary contraction. The outcome will be recorded in seconds, with a longer duration indicating greater ability to sustain the contraction.
8 weeks
Rectal Sensitivity Assessed by Anorectal Manometry
時間枠:8 weeks
Rectal sensitivity will be assessed using graded balloon distension during anorectal manometry. Participants will be instructed to report the first rectal sensation, desire or urgency to defecate, and maximum tolerated sensation during progressive balloon inflation. The corresponding balloon volumes will be recorded in milliliters (mL). Lower sensory threshold volumes indicate greater rectal sensitivity, whereas higher threshold volumes indicate reduced rectal sensitivity.
8 weeks
Rectal Compliance Assessed by Anorectal Manometry
時間枠:8 weeks
Rectal compliance will be assessed during anorectal manometry using controlled rectal balloon distension. Compliance will be determined from the relationship between changes in balloon volume and corresponding changes in steady-state intrarectal pressure (ΔV/ΔP). Higher values indicate greater rectal distensibility, whereas lower values indicate greater resistance to rectal distension.
8 weeks
Health-Related Quality of Life Assessed by the Short Form-36 Health Survey (SF-36)
時間枠:8 weeks
Health-related quality of life will be assessed using the 36-item Short Form Health Survey (SF-36). The questionnaire evaluates eight health domains: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each domain is scored from 0 to 100, with higher scores indicating a more favorable health status.
8 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Mohamed Ahmed Mohamed Awad, PhD、Professor, Cairo University
  • スタディディレクター:Doaa A. Osman, PhD、Ass. Professor, Cairo University
  • スタディディレクター:Hesham Mahmoud Salah El-Din, PhD、Professor, Cairo University
  • 主任研究者:Radwa Ayad Mohamed, M. Sc、PhD Student, Cairo University

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年8月20日

一次修了 (推定)

2026年12月20日

研究の完了 (推定)

2026年12月31日

試験登録日

最初に提出

2026年8月13日

QC基準を満たした最初の提出物

2026年8月13日

最初の投稿 (実際)

2026年8月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月18日

QC基準を満たした最後の更新が送信されました

2026年8月13日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • P.T.REC/012/006002

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する